ARTICLE
1 August 2022

China's New Merger Review Regime

WT
Winston Taylor

Contributor

Whether you're leading the way, disrupting an industry, entering a new phase of growth, or launching a defining product—we're in the room with you. In the action. Sleeves rolled up.

With a rich history spanning both sides of the Atlantic, we are present in the major commercial centers that matter to our clients: the U.S., the U.K., Europe, Latin America, and the Middle East. Combining scale with the speed clients demand, our defining capabilities include major litigation, critical transactions, strategic IP, and private wealth.

Our team of over 1,400 lawyers works hand-in-hand across markets, sectors, practice areas, and client teams. All-in problem solvers, we bring the creativity to think differently, and the pragmatism to get things done when it counts the most.

Embedded in your business and sharing your ambition, we take the work personally. Shaping what we do and how we do it around your goals and needs, always one step ahead of the moment.

China's Anti-Monopoly Law (AML) was significantly amended in June 2022, with changes taking effect August 1, 2022. Businesses contemplating mergers, acquisitions, or joint ventures should be aware...
China Antitrust/Competition Law

China's Anti-Monopoly Law (AML) was significantly amended in June 2022, with changes taking effect August 1, 2022. Businesses contemplating mergers, acquisitions, or joint ventures should be aware of changes to China's premerger notification requirements and substantially increased penalties for failure to file a required notification. These changes can affect any transaction where the parties derive sufficient turnover from China, regardless of whether the parties have any assets or physical presence in China.

In a new FAQ on the AML amendments affecting merger reviews, Winston and YuandaWinston antitrust attorneys in the U.S. and China answer common questions about how the amended AML and accompanying new draft standards proposed by China's antitrust enforcement agency, the State Administration for Market Regulation (SAMR), will affect transactions by non-Chinese companies that sell products into China or whose business may be considered to impact Chinese domestics markets. Issues addressed in the FAQ include:

  • The extent of China's extraterritorial jurisdiction to conduct antitrust review of transactions that occur outside China
  • New thresholds for within-China turnover triggering mandatory premerger notification
  • Forthcoming guidelines from the SAMR to clarify the AML amendments
  • Increased penalties for "gun jumping," the failure to notify SAMR of reportable transactions
  • Statistics on how frequently Chinese antitrust enforcers have imposed conditions on mergers

Guidance from experienced antitrust counsel is always recommended at an early stage of any contemplated deal to evaluate where premerger filings may be required and to navigate the risks. With these AML amendments, Chinese antitrust law continues to evolve and demonstrate that China expects its antitrust enforcers to review any transactions—inside or outside China—that may have a significant effect on domestic Chinese commerce.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

[View Source]

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More